![](https://www.biopharmadive.com/imgproxy/EO6UQXWsUrTrB1k99ZdVkR9I1wk-QPsQetrxkY0Adkc/crop:6335:3579/g:nowe:0:2399/rs:fill:770:435:0/bG9jYWw6Ly8vZGl2ZWltYWdlL29yaWdpbmFsXzEuamZpZg.jpg)
Foundation behind Novo Nordisk to invest $260M in vaccine R&D
Dive Brief: The Novo Nordisk Foundation, which owns a controlling stake in drugmaker Novo Nordisk, said Monday it will invest
Read MoreJuly 4, 2024
Dive Brief: The Novo Nordisk Foundation, which owns a controlling stake in drugmaker Novo Nordisk, said Monday it will invest
Read MoreDive Brief: Venture capital group Pivotal Life Sciences has raised its second fund, securing $389 million to invest in young
Read MoreDive Brief: Vir Biotechnology on Thursday announced a restructuring that will result in a 12% reduction in its workforce as
Read MoreAmgen has a new top scientist, announcing Thursday the appointment of Novartis veteran and prolific biotechnology startup founder Jay Bradner
Read MoreThe committee that recommends whether drugs should be approved in Europe has thrown its support behind the first medicine based
Read MoreDive Brief: The Food and Drug Administration on Thursday broadened use of a drug Merck & Co. acquired in a
Read More